Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Professional development

Outside the Lab Biomedical engineering

The Organ Grower

| Charlotte Barker

Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine

Outside the Lab Clinical trials

The March Towards Trial Transparency

| James Cockerill

Many clinical trial results are never reported, but AllTrials hopes to change that

Outside the Lab Professional development

Human Challenge Trials

| Adrian Wildfire

When biomarkers aren't an option in vaccine research, we need a well-supported alternative

Outside the Lab Professional development

The 100,000 Dollar Question

| William Aryitey

NIDA has launched a $100,000 competition to encourage startup companies

Outside the Lab Cancer

Oncogenetic Pioneer

| Robert A. Weinberg

Sitting Down With… Robert A. Weinberg, founding member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology, USA.

Outside the Lab Professional development

Perfect Partners?

| Abhay Pandit

When it comes to industry–academia partnerships, it’s quality – not quantity – that counts.

Research Field Professional development

Lessons I’ve Learned

| Eric Topol

From being one of the first clinicians to voice doubts over Vioxx, to his latest book calling for a complete transformation of the patient–doctor relationship, Eric Topol has never been afraid to raise his head above the parapet.

Outside the Lab Neuroscience

Counting Sleep

| Thomas Mellman

Sitting Down With… Thomas Mellman, Professor and Director, Center for Clinical and Translational Research and Stress/Sleep Studies Program, Howard University College of Medicine, Washington, DC, USA.

Outside the Lab Professional development

What Price Glory?

| Ann Hayes

The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.

Outside the Lab Genetics

Gene Genie

| John Doench

Sitting Down With…John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register